retatrutide effects clinical trial retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity ESC 2024: Retatrutide improves lipid

, ,

Laboratory findings of markedly elevated B12 levels discovered incidentally should prompt GP review, particularly if you are not taking supplements

Hamadneh L, Bahader M, Abuarqoub R, AlWahsh M, Alhusban A, Hikmat S

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate

Lilly granted one person extraordinary access to its next-gen drug Eli Lilly and the FDA have allowed one person to receive the pharma companys highly promising obesity candidate through the agencys compassionate use program, my colleague Lizzy Lawrence exclusively reports